ABC | Volume 115, Nº1, Julho 2020

Artigo Original Derakhshanian et al. Quercetina melhora a dislipidemia induzida por glicocorticóides Arq Bras Cardiol. 2020; 115(1):102-108 27. Sathe CA, Chogle SA, Bharadwaj D. Apo B/Apo A1 ratio: a risk marker in patients with cardiovascular disease. Int J Res Med. 2017;6(2):20-3. 28. PanayiotouA,GriffinM,GeorgiouN,BondD,TyllisT,Tziakouri-ShiakalliC,etal. ApoB/ApoA1ratioandsubclinicalatherosclerosis.IntAngiol.2008;27(1):74-80. 29. Simpson CW, Dicara LV,Wolf G. Glucocorticoid anorexia in rats. Pharmacol Biochem Behav. 1974;2(1):19-25. 30. Löfberg E, Gutierrez A, Wernerman J, Anderstam B, Mitch WE, Price SR, et al. Effects of high doses of glucocorticoids on free amino acids, ribosomes andproteinturnover inhumanmuscle.Eur JClin Invest.2002;32(5):345-53. 31. Sangeetha KSS, Reddy CUM, Kalkura SN. Flavonoids: therapeutic potential of natural pharmacological agents. Int J PharmSci Res. 2016;7(10):3924-30. 32. Dugani AM, Alkhetally WI, Elghedafi EO, Alkayed FW. Effects of the aqueous extract fromAbelmoschus esculentus L peel on hyperglycemia and hyperlipidemia induced by dexamethasone in rats. Libyan Int. Med. Univ. J. 2018;3(1):3-7. 33. Derakhshanian H, Djalali M, Djazayery A, Nourijelyani K, Ghadbeigi S, Pishva H, et al. Quercetin prevents experimental glucocorticoid-induced osteoporosis: a comparative study with alendronate. Can J Physiol Pharmacol. 2013;91(5):380-5. Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 108